SUNRUN INC (3S9.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:3S9 • US86771W1053

15.336 EUR
-0.83 (-5.16%)
Last: Feb 2, 2026, 07:00 PM
Fundamental Rating

3

3S9 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 67 industry peers in the Electrical Equipment industry. Both the profitability and financial health of 3S9 have multiple concerns. 3S9 is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year 3S9 was profitable.
  • In the past year 3S9 has reported a negative cash flow from operations.
  • 3S9 had negative earnings in 4 of the past 5 years.
  • In the past 5 years 3S9 always reported negative operating cash flow.
3S9.DE Yearly Net Income VS EBIT VS OCF VS FCF3S9.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

  • 3S9 has a worse Return On Assets (-11.10%) than 79.10% of its industry peers.
  • The Return On Equity of 3S9 (-82.67%) is worse than 88.06% of its industry peers.
Industry RankSector Rank
ROA -11.1%
ROE -82.67%
ROIC N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
3S9.DE Yearly ROA, ROE, ROIC3S9.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

  • The Gross Margin of 3S9 (24.15%) is worse than 73.13% of its industry peers.
  • In the last couple of years the Gross Margin of 3S9 has declined.
  • 3S9 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
3S9.DE Yearly Profit, Operating, Gross Margins3S9.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

2

2. Health

2.1 Basic Checks

  • 3S9 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • 3S9 has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 3S9 has been increased compared to 5 years ago.
  • The debt/assets ratio for 3S9 is higher compared to a year ago.
3S9.DE Yearly Shares Outstanding3S9.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
3S9.DE Yearly Total Debt VS Total Assets3S9.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of -0.03, we must say that 3S9 is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.03, 3S9 is doing worse than 82.09% of the companies in the same industry.
  • A Debt/Equity ratio of 4.81 is on the high side and indicates that 3S9 has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 4.81, 3S9 is doing worse than 94.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.81
Debt/FCF N/A
Altman-Z -0.03
ROIC/WACCN/A
WACC4.76%
3S9.DE Yearly LT Debt VS Equity VS FCF3S9.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.46 indicates that 3S9 should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.46, 3S9 perfoms like the industry average, outperforming 58.21% of the companies in the same industry.
  • 3S9 has a Quick Ratio of 1.06. This is a normal value and indicates that 3S9 is financially healthy and should not expect problems in meeting its short term obligations.
  • 3S9 has a Quick ratio of 1.06. This is in the better half of the industry: 3S9 outperforms 62.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.06
3S9.DE Yearly Current Assets VS Current Liabilites3S9.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 250.55% over the past year.
  • Measured over the past years, 3S9 shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.86% on average per year.
  • Looking at the last year, 3S9 shows a quite strong growth in Revenue. The Revenue has grown by 13.79% in the last year.
  • Measured over the past years, 3S9 shows a quite strong growth in Revenue. The Revenue has been growing by 18.87% on average per year.
EPS 1Y (TTM)250.55%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%116.22%
Revenue 1Y (TTM)13.79%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%34.88%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.48% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, 3S9 will show a quite strong growth in Revenue. The Revenue will grow by 12.89% on average per year.
EPS Next Y13.1%
EPS Next 2Y-48.59%
EPS Next 3Y-57.66%
EPS Next 5Y28.48%
Revenue Next Year17.29%
Revenue Next 2Y11.64%
Revenue Next 3Y11.64%
Revenue Next 5Y12.89%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
3S9.DE Yearly Revenue VS Estimates3S9.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
3S9.DE Yearly EPS VS Estimates3S9.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 -6

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 6.64 indicates a rather cheap valuation of 3S9.
  • Compared to the rest of the industry, the Price/Earnings ratio of 3S9 indicates a rather cheap valuation: 3S9 is cheaper than 97.01% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.41, 3S9 is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 57.73, the valuation of 3S9 can be described as expensive.
  • Based on the Price/Forward Earnings ratio, 3S9 is valued a bit more expensive than 70.15% of the companies in the same industry.
  • 3S9 is valuated expensively when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.64
Fwd PE 57.73
3S9.DE Price Earnings VS Forward Price Earnings3S9.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 65.67% of the companies in the same industry are cheaper than 3S9, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 52.64
3S9.DE Per share data3S9.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 3S9's earnings are expected to decrease with -57.66% in the coming years. This may justify a cheaper valuation.
PEG (NY)0.51
PEG (5Y)0.15
EPS Next 2Y-48.59%
EPS Next 3Y-57.66%

0

5. Dividend

5.1 Amount

  • No dividends for 3S9!.
Industry RankSector Rank
Dividend Yield 0%

SUNRUN INC

FRA:3S9 (2/2/2026, 7:00:00 PM)

15.336

-0.83 (-5.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners107.08%
Inst Owner ChangeN/A
Ins Owners2.55%
Ins Owner ChangeN/A
Market Cap3.56B
Revenue(TTM)2.32B
Net Income(TTM)-2.47B
Analysts75.17
Price Target19.49 (27.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)373.38%
Min EPS beat(2)167.72%
Max EPS beat(2)579.04%
EPS beat(4)4
Avg EPS beat(4)390.47%
Min EPS beat(4)167.72%
Max EPS beat(4)646.57%
EPS beat(8)6
Avg EPS beat(8)154.45%
EPS beat(12)8
Avg EPS beat(12)-72.53%
EPS beat(16)10
Avg EPS beat(16)-68.4%
Revenue beat(2)2
Avg Revenue beat(2)10.42%
Min Revenue beat(2)1.67%
Max Revenue beat(2)19.16%
Revenue beat(4)3
Avg Revenue beat(4)4.85%
Min Revenue beat(4)-4.56%
Max Revenue beat(4)19.16%
Revenue beat(8)4
Avg Revenue beat(8)0.95%
Revenue beat(12)6
Avg Revenue beat(12)0.96%
Revenue beat(16)10
Avg Revenue beat(16)4.12%
PT rev (1m)-0.38%
PT rev (3m)-44.27%
EPS NQ rev (1m)40.13%
EPS NQ rev (3m)-162.9%
EPS NY rev (1m)6.83%
EPS NY rev (3m)356.91%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-22.49%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)-21.9%
Valuation
Industry RankSector Rank
PE 6.64
Fwd PE 57.73
P/S 1.82
P/FCF N/A
P/OCF N/A
P/B 1.41
P/tB 1.41
EV/EBITDA 52.64
EPS(TTM)2.31
EY15.06%
EPS(NY)0.27
Fwd EY1.73%
FCF(TTM)-13.32
FCFYN/A
OCF(TTM)-2.82
OCFYN/A
SpS8.43
BVpS10.86
TBVpS10.86
PEG (NY)0.51
PEG (5Y)0.15
Graham Number23.76
Profitability
Industry RankSector Rank
ROA -11.1%
ROE -82.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.15%
FCFM N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 4.81
Debt/FCF N/A
Debt/EBITDA 41.53
Cap/Depr 410.1%
Cap/Sales 124.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.06
Altman-Z -0.03
F-Score3
WACC4.76%
ROIC/WACCN/A
Cap/Depr(3y)457.01%
Cap/Depr(5y)440.93%
Cap/Sales(3y)111.53%
Cap/Sales(5y)108.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)250.55%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%116.22%
EPS Next Y13.1%
EPS Next 2Y-48.59%
EPS Next 3Y-57.66%
EPS Next 5Y28.48%
Revenue 1Y (TTM)13.79%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%34.88%
Revenue Next Year17.29%
Revenue Next 2Y11.64%
Revenue Next 3Y11.64%
Revenue Next 5Y12.89%
EBIT growth 1Y43.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year164.27%
EBIT Next 3Y44.26%
EBIT Next 5YN/A
FCF growth 1Y-5.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.12%
OCF growth 3YN/A
OCF growth 5YN/A

SUNRUN INC / 3S9.DE FAQ

What is the ChartMill fundamental rating of SUNRUN INC (3S9.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 3S9.DE.


What is the valuation status of SUNRUN INC (3S9.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to SUNRUN INC (3S9.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for SUNRUN INC?

SUNRUN INC (3S9.DE) has a profitability rating of 0 / 10.


Can you provide the PE and PB ratios for 3S9 stock?

The Price/Earnings (PE) ratio for SUNRUN INC (3S9.DE) is 6.64 and the Price/Book (PB) ratio is 1.41.


What is the financial health of SUNRUN INC (3S9.DE) stock?

The financial health rating of SUNRUN INC (3S9.DE) is 2 / 10.